A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Clinical trial NCT02963766 · COMPLETED
Trial details
- NCT number
- NCT02963766
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-29
- Primary completion
- 2021-06-12
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.